SAB Biotherapeutics, Inc.

NasdaqCM:SABS Stock Report

Market Cap: US$37.2m

SAB Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:SABS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Dec 23BuyUS$1,531Eddie SullivanIndividual174US$8.80
30 Nov 23BuyUS$4,500Michael KingIndividual500US$9.00
29 Nov 23BuyUS$9,842Samuel ReichIndividual1,100US$8.95

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SABS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies56,2920.61%
Individual Insiders1,400,99215.2%
Hedge Funds1,835,65619.9%
Institutions1,940,88721%
General Public3,991,66743.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 83.1%.


Top Shareholders

Top 25 shareholders own 56.35% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.95%
RTW Investments, LP
917,828US$3.7m0%0.07%
9.95%
BVF Partners L.P.
917,828US$3.7m0%0.09%
5.67%
Eddie Sullivan
523,230US$2.1m0%no data
5.63%
Christine Hamilton
519,232US$2.1m0%no data
4.97%
Marshall Wace LLP
458,528US$1.8m0%no data
4.97%
Sessa Capital IM, L.P.
458,457US$1.8m0%0.09%
3.15%
Edward Hamilton
290,901US$1.2m0%no data
3.1%
Juvenile Diabetes Research Foundation International Inc., Endowment Arm
285,714US$1.2m0%100.0%
2.57%
RA Capital Management, L.P.
237,408US$956.8k0%0.01%
1.99%
Commodore Capital LP
183,174US$738.2k0%0.05%
1.08%
The Vanguard Group, Inc.
99,613US$401.4k1.97%no data
0.59%
Big Cypress Holdings LLC
54,769US$220.7k0%no data
0.55%
Pathstone Family Office, LLC
50,651US$204.1k0%no data
0.43%
Jeffrey Spragens
39,498US$159.2k0%no data
0.39%
Geode Capital Management, LLC
35,636US$143.6k0%no data
0.3%
First Manhattan Co. LLC
27,777US$111.9k0%no data
0.24%
Samuel Reich
21,900US$88.3k0%no data
0.21%
Institutional and Family Asset Management, LLC
19,202US$77.4k0%0.01%
0.18%
Charles Schwab Investment Management, Inc.
16,238US$65.4k900%no data
0.095%
Kestra Advisory Services, LLC
8,800US$35.5k319%no data
0.088%
State Street Global Advisors, Inc.
8,124US$32.7k0%no data
0.075%
Mariner, LLC
6,900US$27.8k0%no data
0.068%
Renaissance Technologies LLC
6,310US$25.4k8.61%no data
0.062%
David Link
5,731US$23.1k0%no data
0.057%
BlackRock, Inc.
5,264US$21.2k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.